PD Dr. habil. med. Claudia A. Staab-Weijnitz, Ph.D. Group Leader “Immune barrier in lung disease”, Institute of Lung Health and Immunity / Spokesperson Environmental Health and Lung Research School +49 89 3187 4681 Visit Email me “Collagen is the most abundant protein in the body, yet we know little…
more
Fibrosis (IPF) is a chronic and lethal fibroproliferative disease of the lung, with unknown etiology. IPF is characterized by progressive fibrosis and irreversible loss of lung function, with a median survival, or time to lung transplantation, of about 3 years after diagnosis. In many organs, innate…
more
Lung fibrosis, or “lung scar” is a chronic disease characterized by excessive fibroblast proliferation, abnormal extracellular matrix deposition, stiffening of alveolar lung tissue, and ultimately loss of lung function. The lack of curative therapies for lung fibrosis not only leads to a high…
more
Lung fibrosis, or “lung scar” is a chronic disease characterized by excessive fibroblast proliferation, abnormal extracellular matrix deposition, stiffening of alveolar lung tissue, and ultimately loss of lung function. The lack of curative therapies for lung fibrosis not only leads to a high…
more
Our lungs are a marvel, but they have a "weak spot", so to speak, because we can't stop breathing! If the air we breathe in is contaminated with pollutants, these fine substances inevitably end up deep in our lungs. Epidemiology now knows that dust particles or nitrogen oxides trigger inflammation…
more
fundamental scientific programs that provide novel therapeutic approaches for chronic lung diseases and explore key environmental triggers. Key research areas include COPD, interstitial lung diseases, lung cancer and lung transplantation. Yildirim places particular emphasis on COPD, which has become…
more
fundamental scientific programs that provide novel therapeutic approaches for chronic lung diseases and explore key environmental triggers. Key research areas include COPD, interstitial lung diseases, lung cancer and lung transplantation. Yildirim places particular emphasis on COPD, which has become…
more
Funk Lab Ageing & Environmental stress in lung disease The Funk laboratory aims to understand how ageing and environmental stress affect the homeostasis and regenerative capacity of the lung epithelium, thereby promoting chronic inflammatory diseases, such as COPD. Based on this, we want to identify…
more
Inhaled medical substances for the treatment of lung diseases are intended for accumulation in the lung. However, a certain fraction of the drug may also reach secondary organs via the blood, which may result in inadvertent side effects. By using a patented mini-lung-model, Helmholtz Munich…
more
that enables the detailed evaluation of fetal organs and tissue, demonstrating a reduction in lung volume in fetuses from SARS-CoV-2 pregnancies – as compared with fetuses from an uninfected reference cohort. “The fetuses of pregnant women who tested positive for SARS-CoV-2 had an overall lower lung…
more